Your browser doesn't support javascript.
loading
Tolerogenic insulin peptide therapy precipitates type 1 diabetes.
Bergman, Marie-Louise; Lopes-Carvalho, Thiago; Martins, Ana-Catarina; Grieco, Fabio A; Eizirik, Décio L; Demengeot, Jocelyne.
Affiliation
  • Bergman ML; Instituto Gulbenkian de Ciência, Oeiras, Portugal.
  • Lopes-Carvalho T; Instituto Gulbenkian de Ciência, Oeiras, Portugal.
  • Martins AC; Instituto Gulbenkian de Ciência, Oeiras, Portugal.
  • Grieco FA; Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
  • Eizirik DL; Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
  • Demengeot J; Instituto Gulbenkian de Ciência, Oeiras, Portugal jocelyne@igc.gulbenkian.pt.
J Exp Med ; 214(7): 2153-2156, 2017 Jul 03.
Article in En | MEDLINE | ID: mdl-28536239

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccination / Diabetes Mellitus, Type 1 / Insulin Limits: Animals / Female / Humans Language: En Journal: J Exp Med Year: 2017 Document type: Article Affiliation country: Portugal Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccination / Diabetes Mellitus, Type 1 / Insulin Limits: Animals / Female / Humans Language: En Journal: J Exp Med Year: 2017 Document type: Article Affiliation country: Portugal Country of publication: United States